A. H. D. Kilian
Research Subjects
A. H. D. Kilian has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
G. Kabagambe
District Health Services, Kabarole District, Uganda
4 shared publicationsF. von Sonnenburg
Department of Infectious Diseases and Tropical Medicine, University of Munich, Germany
2 shared publicationsW. Byamukama
District Health Services, Kabarole District, Uganda
2 shared publicationsA. Talisuna
Malaria Control Unit, Ministry of Health, Uganda
1 shared publication- D. Tindyebwa
Basic Health Services Project, GTZ, Fort Portal, Uganda
1 shared publication E.B. Mughusu
1 shared publication
Latest Publications
- Open Access
- 1 May 2003
- Published by Wiley in Tropical Medicine & International Health
- Vol. 8 (5) , 431-438
Attitude of women in western Uganda towards pre-packed, unit-dosed malaria treatment for children.
- 1 May 2003
- Published by Wiley in Tropical Medicine & International Health
- Vol. 8 (5) , 431-438
Open AccessAttitude of women in western Uganda towards pre-packed, unit-dosed malaria treatment for children.
- 12 April 1999
- Published by Elsevier in Acta Tropica
- Vol. 72 (3) , 281-293
Application of the ParaSight™-F dipstick test for malaria diagnosis in a district control program
- 12 April 1999
- Published by Elsevier in Acta Tropica
- Vol. 72 (3) , 281-293
Application of the ParaSight™-F dipstick test for malaria diagnosis in a district control program
- 1 January 1999
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 93 (1) , 22-23
Rainfall pattern. El Niño and malaria in Uganda
- 1 January 1999
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 93 (1) , 22-23
Rainfall pattern. El Niño and malaria in Uganda
- 1 March 1998
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 92 (2) , 197-200
Resistance in vivo of Plasmodium falciparum to co-trimoxazole in western Uganda
In the context of the ‘integrated management of childhood illnesses’ (IMCI) programme the World Health Organization recommends treating children in malarious areas presenting with fever and respiratory symptoms with co-trimoxazole. In order to verify its effectiveness in uncomplicated Plasmodium falciparum malaria we carried out a study in vivo in western Uganda: 180 children under 5 years old were enrolled and treated with 40/8 mg/kg/d co-trimoxazole over 5 d, and 159 could be followed on days 3, 7 and 14. Effectiveness of treatment was found to be significantly different in various parts of the study area. In Bundibugyo District, bordering République Democratique du Congo (Zaire), 59·1% (39/66) of children were clinically cured after 14 d and 56·1% were parasitologically cured. In the east of Kabarole District (43 children), the figures were 76·7% and 65·1%, respectively. In western Kabarole (50 children) the rates were 96·0% and 90·0%, respectively. We conclude that, in view of the high level of clinical failures in parts of the study area, co-trimoxazole should not be used in the IMCI programme for combined treatment of malaria and pneumonia in the region. Assessment of therapeutic effectiveness of antimalarial drugs needs to consider the microepidemiology of resistance.
- 1 March 1998
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 92 (2) , 197-200
Resistance in vivo of Plasmodium falciparum to co-trimoxazole in western Uganda
In the context of the ‘integrated management of childhood illnesses’ (IMCI) programme the World Health Organization recommends treating children in malarious areas presenting with fever and respiratory symptoms with co-trimoxazole. In order to verify its effectiveness in uncomplicated Plasmodium falciparum malaria we carried out a study in vivo in western Uganda: 180 children under 5 years old were enrolled and treated with 40/8 mg/kg/d co-trimoxazole over 5 d, and 159 could be followed on days 3, 7 and 14. Effectiveness of treatment was found to be significantly different in various parts of the study area. In Bundibugyo District, bordering République Democratique du Congo (Zaire), 59·1% (39/66) of children were clinically cured after 14 d and 56·1% were parasitologically cured. In the east of Kabarole District (43 children), the figures were 76·7% and 65·1%, respectively. In western Kabarole (50 children) the rates were 96·0% and 90·0%, respectively. We conclude that, in view of the high level of clinical failures in parts of the study area, co-trimoxazole should not be used in the IMCI programme for combined treatment of malaria and pneumonia in the region. Assessment of therapeutic effectiveness of antimalarial drugs needs to consider the microepidemiology of resistance.
- 1 November 1997
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 91 (6) , 666-667
Comparison of two rapid, HRP2-based diagnostic tests for Plasmodium falciparum
- 1 November 1997
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 91 (6) , 666-667
Comparison of two rapid, HRP2-based diagnostic tests for Plasmodium falciparum